teprotumumab
Marketedupdated 2mo agoby Horizon Therapeutics USA Inc
Approvedcommunity read0 votes
all catalysts(8)
approval · 8
Jan 21, 2020
approval
TEPEZZA (TEPROTUMUMAB-TRBW) — FDA approval
teprotumumab
→
Oct 26, 2021
approval
TEPEZZA (TEPROTUMUMAB-TRBW) — FDA approval
teprotumumab
→
Dec 6, 2022
approval
TEPEZZA (TEPROTUMUMAB-TRBW) — FDA approval
teprotumumab
→
Apr 13, 2023
approval
TEPEZZA (TEPROTUMUMAB-TRBW) — FDA approval
teprotumumab
→
Jul 17, 2023
approval
TEPEZZA (TEPROTUMUMAB-TRBW) — FDA approval
teprotumumab
→
Aug 26, 2025
approval
TEPEZZA (TEPROTUMUMAB-TRBW) — FDA approval
teprotumumab
→
Sep 9, 2025
approval
TEPEZZA (TEPROTUMUMAB-TRBW) — FDA approval
teprotumumab
→
Nov 24, 2025
approval
TEPEZZA (TEPROTUMUMAB-TRBW) — FDA approval
teprotumumab
→
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that